| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ... New England Journal of Medicine 363 (3), 211-220, 2010 | 1966 | 2010 |
| Birmingham vasculitis activity score (BVAS) Dim system necrotizinig vasculitis RA Luqmani, PA Bacon, RJ Moots, BA Janssen, A Pall, P Emery, ... QJM: An International Journal of Medicine 87 (11), 671-678, 1994 | 1404 | 1994 |
| Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis DRW Jayne, G Gaskin, N Rasmussen, D Abramowicz, F Ferrario, ... Journal of the American Society of Nephrology 18 (7), 2180-2188, 2007 | 1328 | 2007 |
| Genetically distinct subsets within ANCA-associated vasculitis PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ... New England Journal of Medicine 367 (3), 214-223, 2012 | 1065 | 2012 |
| Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial K De Groot, L Harper, DRW Jayne, LF Flores Suarez, G Gregorini, ... Annals of internal medicine 150 (10), 670-680, 2009 | 1035 | 2009 |
| Microscopic polyarteritis: presentation, pathology and prognosis COS SAVAGE, CG Winearls, DJ Evans, AJ Rees, CM Lockwood QJM: An International Journal of Medicine 56 (2), 467-483, 1985 | 737 | 1985 |
| International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) J Savige, D Gillis, E Benson, D Davies, V Esnault, RJ Falk, E Chris Hagen, ... American journal of clinical pathology 111 (4), 507-513, 1999 | 729 | 1999 |
| Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides AR Exley, PA Bacon, RA Luqmani, GD Kitas, C Gordon, COS Savage, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 706 | 1997 |
| Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis: a randomized controlled trial TF Hiemstra, M Walsh, A Mahr, CO Savage, K De Groot, L Harper, ... Jama 304 (21), 2381-2388, 2010 | 651 | 2010 |
| ANCA-associated vasculitis AR Kitching, HJ Anders, N Basu, E Brouwer, J Gordon, DR Jayne, ... Nature reviews Disease primers 6 (1), 71, 2020 | 588 | 2020 |
| Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up L Harper, MD Morgan, M Walsh, P Hoglund, K Westman, O Flossmann, ... Annals of the rheumatic diseases 71 (6), 955-960, 2012 | 507 | 2012 |
| Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis MA Little, P Nightingale, CA Verburgh, T Hauser, K De Groot, C Savage, ... Annals of the rheumatic diseases 69 (6), 1036-1043, 2010 | 496 | 2010 |
| Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis COS Savage, S Jones, CG Winearls, PD Marshall, CM Lockwood The Lancet 329 (8547), 1389-1393, 1987 | 493 | 1987 |
| Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis A Booth, L Harper, T Hammad, P Bacon, M Griffith, J Levy, C Savage, ... Journal of the American Society of Nephrology 15 (3), 717-721, 2004 | 488 | 2004 |
| The value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical review K Groot, D Adu, COS Savage Nephrology Dialysis Transplantation 16 (10), 2018-2027, 2001 | 428 | 2001 |
| A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis RB Jones, AJ Ferraro, AN Chaudhry, P Brogan, AD Salama, KGC Smith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 420 | 2009 |
| Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. CO Savage, BE Pottinger, G Gaskin, CD Pusey, JD Pearson The American journal of pathology 141 (2), 335, 1992 | 343 | 1992 |
| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial RB Jones, S Furuta, JWC Tervaert, T Hauser, R Luqmani, MD Morgan, ... Annals of the rheumatic diseases 74 (6), 1178-1182, 2015 | 316 | 2015 |
| Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. CO Savage, CD Pusey, C Bowman, AJ Rees, CM Lockwood Br Med J (Clin Res Ed) 292 (6516), 301-304, 1986 | 313 | 1986 |
| Primary systemic vasculitis COS Savage, L Harper, D Adu The Lancet 349 (9051), 553-558, 1997 | 304 | 1997 |
